Skip to main content

23.11.2019 | Letter to the Editor

Effect of atorvastatin on rheumatoid arthritis–associated autoreactive T cells

verfasst von: Christian A. Koch, Siegfried Krabbe, Bernd Hehmke

Erschienen in: Immunologic Research

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
3.
Zurück zum Zitat Zeiser R. Immune modulatory effects of statins. Immunology. 2018;154(1):69–75.CrossRef Zeiser R. Immune modulatory effects of statins. Immunology. 2018;154(1):69–75.CrossRef
4.
Zurück zum Zitat Koch CA, Antonelli A. Immunoendocrinology: when (neuro)endocrinology and immunology meet. Rev Endocr Metab Disord. 2018;19(4):277–82.CrossRef Koch CA, Antonelli A. Immunoendocrinology: when (neuro)endocrinology and immunology meet. Rev Endocr Metab Disord. 2018;19(4):277–82.CrossRef
6.
Zurück zum Zitat Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Torres-Aguilar H, Navarro C, et al. Prolactin has a pathogenic role in systemic lupus erythematosus. Immunol Res. 2017;65(2):512–23.CrossRef Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Torres-Aguilar H, Navarro C, et al. Prolactin has a pathogenic role in systemic lupus erythematosus. Immunol Res. 2017;65(2):512–23.CrossRef
7.
Zurück zum Zitat Karpouzas GA, Ormseth SR, Hernandez E, Budoff MJ. Impact of cumulative inflammation, cardiac risk factors and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis. Arthritis Rheum. 2019. https://doi.org/10.1002/art.41122. Karpouzas GA, Ormseth SR, Hernandez E, Budoff MJ. Impact of cumulative inflammation, cardiac risk factors and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis. Arthritis Rheum. 2019. https://​doi.​org/​10.​1002/​art.​41122.
8.
Zurück zum Zitat Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF. Symmons DPM; TRACE RA Consortium. A Mmulticenter, Rrandomized, Pplacebo-Ccontrolled Ttrial of Aatorvastatin for the Pprimary Pprevention of Ccardiovascular Eevents in Ppatients Wwith Rrheumatoid Aarthritis. Arthritis Rheum. 2019;71(9):1437–49.CrossRef Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF. Symmons DPM; TRACE RA Consortium. A Mmulticenter, Rrandomized, Pplacebo-Ccontrolled Ttrial of Aatorvastatin for the Pprimary Pprevention of Ccardiovascular Eevents in Ppatients Wwith Rrheumatoid Aarthritis. Arthritis Rheum. 2019;71(9):1437–49.CrossRef
9.
Zurück zum Zitat Soulaidopoulos S, Nikiphorou E, Dimitroulas T, Kitas GD. The role of statins in disease modification and cardiovascular risk in rheumatoid arthritis. Front Med (Lausanne). 2018;5:24.CrossRef Soulaidopoulos S, Nikiphorou E, Dimitroulas T, Kitas GD. The role of statins in disease modification and cardiovascular risk in rheumatoid arthritis. Front Med (Lausanne). 2018;5:24.CrossRef
10.
Zurück zum Zitat Li GM, Zhao J, Li B, Zhang XF, Ma JX, Ma XL, et al. The anti-inflammatory effects of statins on patients with rheumatoid arthritis: a systemic review and meta-analysis of 15 randomized controlled trials. Autoimmun Rev. 2018 Mar;17(3):215–25.CrossRef Li GM, Zhao J, Li B, Zhang XF, Ma JX, Ma XL, et al. The anti-inflammatory effects of statins on patients with rheumatoid arthritis: a systemic review and meta-analysis of 15 randomized controlled trials. Autoimmun Rev. 2018 Mar;17(3):215–25.CrossRef
Metadaten
Titel
Effect of atorvastatin on rheumatoid arthritis–associated autoreactive T cells
verfasst von
Christian A. Koch
Siegfried Krabbe
Bernd Hehmke
Publikationsdatum
23.11.2019
Verlag
Springer US
Erschienen in
Immunologic Research
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-019-09105-8

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.